Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$247K Hold
1,679
0.1% 121
2025
Q4
$327K Hold
1,679
0.13% 104
2025
Q3
$472K Hold
1,679
0.11% 81
2025
Q2
$367K Buy
1,679
+423
+34% +$68.3K 0.19% 85
2025
Q1
$176K Hold
1,256
0.1% 102
2024
Q4
$209K Hold
1,256
0.12% 94
2024
Q3
$214K Hold
1,256
0.11% 99
2024
Q2
$177K Hold
1,256
0.12% 97
2024
Q1
$158K Hold
1,256
0.11% 102
2023
Q4
$132K Hold
1,256
0.1% 107
2023
Q3
$133K Hold
1,256
0.11% 106
2023
Q2
$150K Buy
1,256
+186
+17% +$19.2K 0.12% 98
2023
Q1
$99.4K Hold
1,070
0.09% 113
2022
Q4
$87.5K Hold
1,070
0.07% 136
2022
Q3
$65K Hold
1,070
0.06% 141
2022
Q2
$75K Sell
1,070
-58
-5% -$4.25K 0.06% 151
2022
Q1
$93K Hold
1,128
0.06% 153
2021
Q4
$98K Hold
1,128
0.06% 164
2021
Q3
$98K Buy
1,128
+58
+5% +$5.12K 0.06% 176
2021
Q2
$83K Hold
1,070
0.1% 176
2021
Q1
$75K Buy
+1,070
New +$69.3K 0.1% 174
2020
Q4
Sell
-887
Closed -$53K 173
2020
Q3
$53K Hold
887
0.12% 126
2020
Q2
$49K Sell
887
-100
-10% -$5.3K 0.12% 115
2020
Q1
$48K Buy
987
+360
+57% +$18.6K 0.18% 82
2019
Q4
$33K Buy
+627
New +$34.5K 0.07% 140

Other funds holding ORCL

Solstein Capital's ORCL Position: Q1 2026 in Review

Solstein Capital held its Oracle (ORCL) position steady in Q1 2026 at 1,679 shares worth $247K. The position accounts for 0.1% of the portfolio, ranked #121.

Solstein Capital first reported a position in ORCL in Q4 2019 and has held it in 25 quarters since. The position peaked at $472K in Q3 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Solstein Capital held 1,679 shares of Oracle worth $247K as of Q1 2026.
  • Solstein Capital left its Oracle share count unchanged in Q1 2026.
  • Oracle made up 0.1% of Solstein Capital's portfolio in Q1 2026, its #121 holding.
  • Solstein Capital first reported a position in Oracle in Q4 2019 and has held it in 25 quarters since.
  • Solstein Capital's Oracle position peaked at $472K in Q3 2025.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.